Gene therapy for bypass graft failure and restenosis

Publisher： Karger

E-ISSN： 1424-8840|32|5-6|389-391

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.5-6, 2003-08, pp. : 389-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gene therapy for heart failure

By Thompson Richard   Rungwerth Katrin   Koch Walter  

Annals of Medicine, Vol. 36, Iss. 1, 2004-05 ,pp. : 106-115

Informa Healthcare

Access to resources Recommend Favorite

Tissue Inhibitor of Metalloproteinase 1 Adenoviral Gene Therapy Alone Is Equally Effective in Reducing Restenosis as Combination Gene Therapy in a Rabbit Restenosis Model

By  

Journal of Vascular Research, Vol. 42, Iss. 5, 2005-09 ,pp. : 361-367

Karger

Access to resources Recommend Favorite

Restenosis and Gene Polymorphisms

By  

Cardiology, Vol. 112, Iss. 4, 2008-08 ,pp. : 260-262

Karger

Access to resources Recommend Favorite

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: Comparison of fibrinogen concentrate with allogeneic blood products

By Solomon Cristina   Schöchl Herbert   Hanke Alexander   Calatzis Andreas   Hagl Christian   Tanaka Kenichi   Rahe-Meyer Niels  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 2, 2012-04 ,pp. : 121-128

Informa Healthcare

Access to resources Recommend Favorite

Additional Stem Cell Therapy for Graft Failure after Allogeneic Bone Marrow Transplantation

By  

Acta Haematologica, Vol. 104, Iss. 4, 2001-03 ,pp. : 185-192

Karger

Access to resources Recommend Favorite